UB Paderborn / Katalog / Suche / in CDI

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures

Clinical gastroenterology and hepatology, 2018-11, Vol.16 (11), p.1832-1833

2018

Volltextzugriff (PDF)

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

Gut microbes, 2020-01, Vol.11 (1), p.51-62

2020

Volltextzugriff (PDF)

Long Term Efficacy and Safety Profile of Fecal Transplants for Treatment of Recurrent C. difficile Infection: 124

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S67-S67

2018

Volltextzugriff (PDF)

Quality of Bowel Preparation does not Affect Outcome of Fecal Microbiota Transplantation for the Therapy Clostridium Difficile Infection

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1004-S1005

2017

Volltextzugriff (PDF)

Should we Recommend Anti- Clostridium Difficile Antibiotic or Probiotic Prophylaxis?: Risk of Clostridium Difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1005-S1005

2017

Volltextzugriff (PDF)

Fecal Microbiota Transplantation is Safe and Effective for the Treatment of Clostridium Difficile Infection in Solid Organ Transplant Recipients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1005-S1005

2017

Volltextzugriff (PDF)

Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach

Gut microbes, 2017-05, Vol.8 (3), p.289-302

2017

Volltextzugriff (PDF)

Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection

Clinical gastroenterology and hepatology, 2020-09, Vol.18 (10), p.2234-2243.e1

2020

Volltextzugriff (PDF)

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2402-2409

2016

Volltextzugriff (PDF)

Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study

The American journal of gastroenterology, 2016-07, Vol.111 (7), p.1024-1031

2016

Volltextzugriff (PDF)

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience

American journal of transplantation, 2019-02, Vol.19 (2), p.501-511

2019

Volltextzugriff (PDF)

Response to Bodiwala and Skole

The American journal of gastroenterology, 2017-02, Vol.112 (2), p.391-392

2017

Volltextzugriff (PDF)

Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?

Digestive diseases and sciences, 2019-06, Vol.64 (6), p.1668-1671

2019

Volltextzugriff (PDF)

Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis

Clinical gastroenterology and hepatology, 2021-08, Vol.19 (8), p.1627-1634

2021

Volltextzugriff (PDF)

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection

Inflammatory bowel diseases, 2021-08, Vol.27 (9), p.1371-1378

2021

Volltextzugriff (PDF)

Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment

Clinical microbiology and infection, 2018-07, Vol.24 (7), p.780.e1-780.e3

2018

Volltextzugriff (PDF)

121 ULCERATIVE COLITIS PATIENTS ACHEIVE MORE ROBUST ENGRAFTMENT COMPARED TO PATIENTS WITH CROHN'S DISEASE AFTER FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF RECURRENT C. DIFFICLE INFECTION

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-22-S-22

2020

Volltextzugriff (PDF)

Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks After Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint: 2016 ACG Category Award (Colon): 117

The American journal of gastroenterology, 2016-10, Vol.111, p.S56

2016

Volltextzugriff (PDF)

Fecal Microbiota Transplant Decreases Mortality in Patients With Refractory Severe and Severe Complicated Clostridium difficile Infection Not Eligible for Colectomy: 2017 Fellows-in-Training Award (Colon Category): 100

The American journal of gastroenterology, 2017-10, Vol.112, p.S48

2017

Volltextzugriff (PDF)

93 Long-term Risk of Clostridium difficile Infection Recurrence With or Without Antibiotic Exposure Following Successful Fecal Microbiota Transplant

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S23-S23

2016

Volltextzugriff (PDF)

Tu1914 - Should we Recommend Anti- Clostridium Difficile Antibiotic or Probiotic Prophylaxis?: Risk of Clostridium Difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1005-S1005

2017

Volltextzugriff (PDF)

837 Short Chain Fatty Acid Profiles Are Altered by Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S484-S485

2019

Volltextzugriff (PDF)

Tu1894 - Potential Motivators and Deterents for Stool Donors: A Multicenter Study

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1051-S-1051

2018

Volltextzugriff (PDF)

Clostridium difficile PCR Testing Post Fecal Microbiota Transplantation (FMT) Predicts Success: 1329

The American journal of gastroenterology, 2015-10, Vol.110, p.S580

2015

Volltextzugriff (PDF)

Predictors of Failure After Fecal Microbiota Transplantation (FMT) for the Therapy of Clostridium difficile Infection (CDI): 1335

The American journal of gastroenterology, 2015-10, Vol.110, p.S582

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

Long Term Efficacy and Safety Profile of Fecal Transplants for Treatment of Recurrent C. difficile Infection: 124

Quality of Bowel Preparation does not Affect Outcome of Fecal Microbiota Transplantation for the Therapy Clostridium Difficile Infection

Should we Recommend Anti- Clostridium Difficile Antibiotic or Probiotic Prophylaxis?: Risk of Clostridium Difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant

Fecal Microbiota Transplantation is Safe and Effective for the Treatment of Clostridium Difficile Infection in Solid Organ Transplant Recipients

Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach

Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience

Response to Bodiwala and Skole

Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?

Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection

Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment

121 ULCERATIVE COLITIS PATIENTS ACHEIVE MORE ROBUST ENGRAFTMENT COMPARED TO PATIENTS WITH CROHN'S DISEASE AFTER FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF RECURRENT C. DIFFICLE INFECTION

Redefining Cure in Clostridium difficile Infection: Clinical Assessment 4 Weeks After Fecal Microbiota Transplantation Is Predictive of Standard 8-week Cure Endpoint: 2016 ACG Category Award (Colon): 117

Fecal Microbiota Transplant Decreases Mortality in Patients With Refractory Severe and Severe Complicated Clostridium difficile Infection Not Eligible for Colectomy: 2017 Fellows-in-Training Award (Colon Category): 100

93 Long-term Risk of Clostridium difficile Infection Recurrence With or Without Antibiotic Exposure Following Successful Fecal Microbiota Transplant

Tu1914 - Should we Recommend Anti- Clostridium Difficile Antibiotic or Probiotic Prophylaxis?: Risk of Clostridium Difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant

837 Short Chain Fatty Acid Profiles Are Altered by Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection

Tu1894 - Potential Motivators and Deterents for Stool Donors: A Multicenter Study

Clostridium difficile PCR Testing Post Fecal Microbiota Transplantation (FMT) Predicts Success: 1329

Predictors of Failure After Fecal Microbiota Transplantation (FMT) for the Therapy of Clostridium difficile Infection (CDI): 1335

Suchergebnisse filtern